Reports a photochemical method transforming isoquinolines into naphthalenes, suggesting efficient drug development pathways.
Isosteric replacement is an important strategy for lead optimization in drug-development paradigms. However, it is usually restricted to cost- and labor-intensive de novo syntheses. We here report a photochemical photosensitizer-free skeletal-editing strategy to directly transform easily accessible isoquinolines into synthetically challenging naphthalene derivatives in a single operation. Directed by density functional theory calculations, the key factor enabling the (4 + 2) cycloaddition between two polarity-mismatched species was harnessing photonic energy to overcome fundamental electronic hurdles by the combination of isoquinolinium carbonate as the electron-donor-acceptor complex. The high compatibility of this methodology was expanded to late-stage functionalization of commercial drugs, thus enriching optimization libraries. Importantly, value-adding access to valuable polycyclic aromatic hydrocarbons, numerous ligands and drug analogies is also demonstrated.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: